CSBTF fundamentals
An in-depth look to Kuros Bioscience Ltd. operating, investing, and financing activities
CSBTF free cash flow for H2 23 is -2.77 M USD. For 2023, CSBTF free cash flow was -10.88 M USD and operating cash flow was -10.5 M USD.
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: USD
TTM